Sudarshan Pharma Industries is submitting the Unaudited Standalone and Consolidated Financial Results for the quarter ended…
Sudarshan Pharma Industries (SUDARSHAN) said it is submitting the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026.
What happened
In a filing with the BSE on 29 October 2026 at 10:26 PM, Sudarshan Pharma Industries (SUDARSHAN) said that it is submitting the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026.
Company snapshot
SUDARSHAN is a listed company.
The stock last traded at ₹37.48, against a 52-week range of ₹36.5–₹39.3 (4.6% below the high).
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Market-wide, 10,043 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 29 October 2026: Board meeting — Financial Results/Fund Raising.
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.